Clinical Trials
23 trialsNCT04975152 2026-05-27
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Recruiting
NCT07422805 2026-05-27
ctDNA
Institute of Oncology Ljubljana
Phase 1/2 Active not recruiting
NCT06279143 2026-05-26
dOCT-pBCC
Vejle Hospital
Completed
NCT07606287 2026-05-26
Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Ohio State University Comprehensive Cancer Center
Phase NA Not yet recruiting
NCT00040352 2026-05-22
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
National Institutes of Health Clinical Center (CC)
Recruiting
NCT04267861 2026-05-22
M7824 Related Adverse Effects in Adults With Cancer
National Institutes of Health Clinical Center (CC)
Active not recruiting
NCT06489301 2026-05-22
Mechanisms for Laser-Induced Rejuvenation
Wright State University
Phase NA Recruiting
NCT07330323 2026-05-22
CARES
Universitaire Ziekenhuizen KU Leuven
Phase NA Recruiting
NCT07600476 2026-05-20
A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors
Kupando GmbH
Phase 1 Recruiting
NCT05779423 2026-05-19
Cryoablation+Ipilimumab+Nivolumab in Melanoma
Massachusetts General Hospital
Phase 2 Recruiting
NCT05574101 2026-05-15
A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT05715255 2026-05-14
Adaptive Symptom Self-Management Immunotherapy Study
University of Arizona
Phase NA Recruiting
NCT06673329 2026-05-13
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
Phase 1 Recruiting
NCT07455331 2026-05-11
LANCE
Jules Bordet Institute
Phase 2 Not yet recruiting
NCT07575230 2026-05-11
Suzetrigine vs Norco-postoperative Mohs Pain
Baylor Research Institute
Phase 4 Enrolling by invitation
NCT02621021 2026-05-08
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT05655494 2026-05-08
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
Recruiting
NCT06295809 2026-05-08
INTerpath-007
Merck Sharp & Dohme LLC
Phase 2/3 Terminated
NCT06870487 2026-05-08
A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
Pfizer
Phase 1 Terminated
NCT00001813 2026-05-07
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
National Institutes of Health Clinical Center (CC)
Completed
NCT06384924 2026-05-07
Raman Spectroscopy and Skin Cancer
Stony Brook University
Recruiting
NCT03503240 2026-05-06
Patient Satisfaction With Appearance, Scar Outcome and Quality of Life After Skin Cancer Surgery
Memorial Sloan Kettering Cancer Center
Enrolling by invitation
NCT02012699 2026-05-05
iCaRe2
University of Nebraska
Recruiting